vs

Side-by-side financial comparison of Axogen, Inc. (AXGN) and Honest Company, Inc. (HNST). Click either name above to swap in a different company.

Honest Company, Inc. is the larger business by last-quarter revenue ($78.1M vs $61.5M, roughly 1.3× Axogen, Inc.). On growth, Axogen, Inc. posted the faster year-over-year revenue change (26.6% vs -19.7%). Over the past eight quarters, Axogen, Inc.'s revenue compounded faster (13.3% CAGR vs -8.4%).

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

The Honest Company, Inc. is an American digital-first consumer goods company, based in Los Angeles and founded by actress Jessica Alba, Christopher Gavigan, and Brian Lee. The company had $319 million in 2021 sales, and was valued at roughly $550 million as of February 2022. Carla Vernón, Chief Executive Officer, is one of the first Afro-Latina CEOs of a U.S. publicly traded company. The Honest Company has raised multiple rounds of venture capital, and went public via an initial public offeri...

AXGN vs HNST — Head-to-Head

Bigger by revenue
HNST
HNST
1.3× larger
HNST
$78.1M
$61.5M
AXGN
Growing faster (revenue YoY)
AXGN
AXGN
+46.3% gap
AXGN
26.6%
-19.7%
HNST
Faster 2-yr revenue CAGR
AXGN
AXGN
Annualised
AXGN
13.3%
-8.4%
HNST

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AXGN
AXGN
HNST
HNST
Revenue
$61.5M
$78.1M
Net Profit
$-19.6M
Gross Margin
75.2%
42.6%
Operating Margin
20.2%
56.6%
Net Margin
-31.9%
Revenue YoY
26.6%
-19.7%
Net Profit YoY
-410.8%
EPS (diluted)
$-0.38
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXGN
AXGN
HNST
HNST
Q1 26
$61.5M
$78.1M
Q4 25
$59.9M
$88.0M
Q3 25
$60.1M
$92.6M
Q2 25
$56.7M
$93.5M
Q1 25
$48.6M
$97.3M
Q4 24
$49.4M
$99.8M
Q3 24
$48.6M
$99.2M
Q2 24
$47.9M
$93.0M
Net Profit
AXGN
AXGN
HNST
HNST
Q1 26
$-19.6M
Q4 25
$-13.2M
$-23.6M
Q3 25
$708.0K
$758.0K
Q2 25
$579.0K
$3.9M
Q1 25
$-3.8M
$3.3M
Q4 24
$450.0K
$-809.0K
Q3 24
$-1.9M
$165.0K
Q2 24
$-1.9M
$-4.1M
Gross Margin
AXGN
AXGN
HNST
HNST
Q1 26
75.2%
42.6%
Q4 25
74.1%
15.7%
Q3 25
76.6%
37.3%
Q2 25
74.2%
40.4%
Q1 25
71.9%
38.7%
Q4 24
76.1%
38.8%
Q3 24
74.9%
38.7%
Q2 24
73.8%
38.3%
Operating Margin
AXGN
AXGN
HNST
HNST
Q1 26
20.2%
56.6%
Q4 25
-16.3%
-27.5%
Q3 25
3.2%
0.3%
Q2 25
3.0%
3.1%
Q1 25
-3.4%
2.6%
Q4 24
4.1%
-1.0%
Q3 24
-0.6%
0.1%
Q2 24
-0.9%
-4.3%
Net Margin
AXGN
AXGN
HNST
HNST
Q1 26
-31.9%
Q4 25
-22.0%
-26.8%
Q3 25
1.2%
0.8%
Q2 25
1.0%
4.1%
Q1 25
-7.9%
3.3%
Q4 24
0.9%
-0.8%
Q3 24
-3.8%
0.2%
Q2 24
-4.0%
-4.4%
EPS (diluted)
AXGN
AXGN
HNST
HNST
Q1 26
$-0.38
$0.00
Q4 25
$-0.28
$-0.21
Q3 25
$0.01
$0.01
Q2 25
$0.01
$0.03
Q1 25
$-0.08
$0.03
Q4 24
$-0.00
$-0.01
Q3 24
$-0.04
$0.00
Q2 24
$-0.04
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXGN
AXGN
HNST
HNST
Cash + ST InvestmentsLiquidity on hand
$82.7M
$90.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$244.8M
$169.1M
Total Assets
$289.5M
$214.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXGN
AXGN
HNST
HNST
Q1 26
$82.7M
$90.4M
Q4 25
$41.5M
$89.6M
Q3 25
$35.8M
$71.5M
Q2 25
$29.9M
$72.1M
Q1 25
$22.1M
$72.8M
Q4 24
$33.5M
$75.4M
Q3 24
$24.5M
$53.4M
Q2 24
$21.1M
$36.6M
Total Debt
AXGN
AXGN
HNST
HNST
Q1 26
Q4 25
$48.4M
Q3 25
$48.2M
Q2 25
$47.9M
Q1 25
$47.7M
Q4 24
$47.5M
Q3 24
$47.3M
Q2 24
$47.0M
Stockholders' Equity
AXGN
AXGN
HNST
HNST
Q1 26
$244.8M
$169.1M
Q4 25
$128.8M
$169.7M
Q3 25
$120.8M
$190.2M
Q2 25
$112.3M
$187.0M
Q1 25
$105.4M
$180.4M
Q4 24
$103.9M
$174.3M
Q3 24
$99.4M
$133.9M
Q2 24
$95.7M
$129.7M
Total Assets
AXGN
AXGN
HNST
HNST
Q1 26
$289.5M
$214.9M
Q4 25
$221.7M
$225.4M
Q3 25
$216.4M
$241.5M
Q2 25
$205.5M
$249.0M
Q1 25
$196.2M
$265.3M
Q4 24
$203.7M
$247.4M
Q3 24
$192.0M
$209.2M
Q2 24
$188.9M
$200.2M
Debt / Equity
AXGN
AXGN
HNST
HNST
Q1 26
Q4 25
0.38×
Q3 25
0.40×
Q2 25
0.43×
Q1 25
0.45×
Q4 24
0.46×
Q3 24
0.48×
Q2 24
0.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXGN
AXGN
HNST
HNST
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-1.4M
FCF MarginFCF / Revenue
-2.3%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXGN
AXGN
HNST
HNST
Q1 26
Q4 25
$3.0M
$19.3M
Q3 25
$3.2M
$-504.0K
Q2 25
$7.7M
$-745.0K
Q1 25
$-13.2M
$-2.9M
Q4 24
$8.7M
$-16.8M
Q3 24
$3.9M
$15.1M
Q2 24
$4.2M
$2.9M
Free Cash Flow
AXGN
AXGN
HNST
HNST
Q1 26
$-1.4M
Q4 25
$1.8M
$18.1M
Q3 25
$1.7M
$-624.0K
Q2 25
$7.0M
$-826.0K
Q1 25
$-13.4M
$-3.0M
Q4 24
$8.1M
$-17.2M
Q3 24
$3.3M
$15.0M
Q2 24
$3.3M
$2.9M
FCF Margin
AXGN
AXGN
HNST
HNST
Q1 26
-2.3%
Q4 25
3.0%
20.5%
Q3 25
2.8%
-0.7%
Q2 25
12.4%
-0.9%
Q1 25
-27.7%
-3.1%
Q4 24
16.3%
-17.2%
Q3 24
6.8%
15.1%
Q2 24
6.8%
3.1%
Capex Intensity
AXGN
AXGN
HNST
HNST
Q1 26
0.6%
Q4 25
2.1%
1.4%
Q3 25
2.5%
0.1%
Q2 25
1.3%
0.1%
Q1 25
0.5%
0.1%
Q4 24
1.4%
0.3%
Q3 24
1.2%
0.1%
Q2 24
1.9%
0.0%
Cash Conversion
AXGN
AXGN
HNST
HNST
Q1 26
Q4 25
Q3 25
4.55×
-0.66×
Q2 25
13.35×
-0.19×
Q1 25
-0.90×
Q4 24
19.41×
Q3 24
91.42×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons